INSIGHTS ON DRUG DEVELOPMENT
-
![GettyImages-1356994439-stem-cell-DNA-gene-editing-tweezers]( "Versatile Lipid Nanoparticle Platform For Efficient Gene Editing")
Versatile Lipid Nanoparticle Platform For Efficient Gene EditingLipid nanoparticles enable efficient gene editing in hard-to-transfect cells like T-cells and blood stem cells, which offers scalable, clinically relevant methods for developing advanced therapies for cancer and rare diseases.
-
![GettyImages-1389723406 protein]( "Comprehensive Workflow For The Quantification Of Peptides And Proteins")
Comprehensive Workflow For The Quantification Of Peptides And ProteinsBiologics are transforming medicine, with semaglutide leading the way. Discover how an automated LC-MS/MS workflow enables high-sensitivity quantification of peptides in plasma.
-
![Addressing Raw Material Handling Challenges By Dry Granulation]( "Addressing Raw Material Handling Challenges By Dry Granulation")
Addressing Raw Material Handling Challenges By Dry GranulationHandling multi-ton quantities of buffers, salts, and stabilizing chemicals in manufacturing can be difficult. Discover how dry granulation improves efficiency, safety, and process reliability.
-
![GettyImages-2187764040-cell-culture-testing-manufacturing-in-lab]( "A Comparison To Traditional Clone Screening Platforms")
A Comparison To Traditional Clone Screening PlatformsSee how 46 CHO clones performed across automated, deep-well, and microbioreactor fed-batch cultures, using cell density, viability, and IgG concentration to evaluate clone performance.
-
Advancements In GLP-1 Analog Formulation: Overcoming Challenges2/3/2025
Oral GLP-1 formulations represent a groundbreaking advance in obesity treatment to offer improved patient comfort and adherence while expanding the therapeutic market.
-
AAV Downstream Challenges: Expert Insights5/22/2025
Gain expert insight into the complexities of AAV purification to learn how industry leaders tackle downstream challenges, optimize workflows, and drive innovation in scalable, efficient gene therapy manufacturing solutions.
-
Overview Of Hot Melt Extrusion And Its Pharmaceutical Applications8/31/2026
More than 40% of NCEs face aqueous solubility challenges. Here, we examine how hot melt extrusion addresses solubility, modified release, abuse deterrence, and scale-up across pharmaceutical development.
-
Enabling Flexibility And Scientific Innovation In OSD Development8/31/2026
How one clinical-stage CNS biotech navigated early formulation complexity, shifting pipeline priorities, and scalable manufacturing demands through a strategic CDMO partnership.
-
LC-UV-Based Synthetic Peptide Impurity Tracking And Reporting7/29/2025
Explore a UPLC-UV method using Empower 3 Software to assess synthetic peptide purity. Learn how integrated tools streamline impurity tracking, data reporting, and compliance in peptide analysis workflows.
DRUG DEVELOPMENT SOLUTIONS
-
![high-potency-manufacturing-GettyImages-1731682643]( "High Potency API Development And Manufacturing")
Our HPAPI development and manufacturing spans preclinical through commercial supply across 13 global sites, with SafeBridge-certified containment and 30 years of cytotoxic compound expertise.
-
![Scientist Using Tablet In Lab GettyImages-1354172577]( "PBPK Predictive Modeling Services")
Early identification of potential absorption risks is critical for rapid and efficient drug development. Lonza's PBPK modeling services are designed to de-risk your drug development program.
-
![GettyImages-923626190-magnifying-glass-pill-tablets-powder]( "API Stability Combined With Rapid Disintegration")
Enhance tablet effectiveness across various dosages with an excipient that offers excellent compressibility and stability for APIs, which eliminates the need for intense processing and provides rapid disintegration.
-
![How SimpleStep ELISA Works]( "Sandwich ELISA Assays For Unparalleled Simplicity And Effectiveness")
SimpleStep ELISA® kits are sandwich ELISA assays that we have developed to be as simple and effective as possible. Unlike traditional sandwich ELISAs, which take more than three hours to run, SimpleStep ELISA kits generate data in just 90 minutes without compromising performance, using only one wash step and recombinant antibodies for exceptional specificity.
-
![GettyImages-1441662840-lab-team-communication-collaboration]( "Integrated Programs To Bridge Molecules From Discovery Into Clinical Development")
A new collaboration helps to remove obstacles from the critical path, reduce development risks, eliminate the white space in pre-clinical drug development, and shorten the pathway to clinical development.
